ArticleCureus2026
Prolonged Primary Cytomegalovirus Infection in an Immunocompetent Adult Successfully Treated With Valganciclovir.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytomegalovirus (CMV) infection in immunocompetent adults is generally asymptomatic or causes a mild, self-limited illness, but it may occasionally present as CMV mononucleosis with prolonged fever. We report a case of primary CMV infection in an immunocompetent adult presenting with prolonged fever and subsequent clinical improvement following antiviral therapy. A 26-year-old woman presented with a three-week history of intermittent fever reaching 39°C. Laboratory findings revealed atypical lymphocytes and elevated liver enzymes. Serological findings were consistent with primary CMV infection. Despite supportive care, the fever and liver dysfunction persisted, and CMV antigenemia was subsequently found to be positive. Valganciclovir was initiated, and the patient became afebrile within five days, followed by improvement in the laboratory abnormalities. This case highlights that primary CMV infection in immunocompetent adults can cause prolonged fever lasting more than five weeks. In selected patients with persistent symptoms and evidence of ongoing viral activity, antiviral therapy may warrant consideration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.